Neuroprotective Effects of Propofol in Models of Cerebral Ischemia: Inhibition of Mitochondrial Swelling as a Possible Mechanism
Adembri, Chiara M.D., Ph.D.*; Venturi, Luna M.D.†; Tani, Alessia B.Sc.‡; Chiarugi, Alberto M.D., Ph.D.§; Gramigni, Elena M.D.†; Cozzi, Andrea B.Sc.#; Pancani, Tristano B.Sc.**; De Gaudio, Raffaele A. M.D.††; Pellegrini-Giampietro, Domenico E. M.D., Ph.D.§
Background: Propofol (2,6-diisopropylphenol) has been shown to attenuate neuronal injury in a number of experimental conditions, but studies in models of cerebral ischemia have yielded conflicting results. Moreover, the mechanisms involved in its neuroprotective effects are yet unclear.
Methods: The authors evaluated the neuroprotective effects of propofol in rat organotypic hippocampal slices exposed to oxygen-glucose deprivation, an in vitro model of cerebral ischemia. To investigate its possible mechanism of action, the authors then examined whether propofol could reduce Ca2+-induced rat brain mitochondrial swelling, an index of mitochondrial membrane permeability, as well as the mitochondrial swelling evoked by oxygen-glucose deprivation in CA1 pyramidal cells by transmission electron microscopy. Finally, they evaluated whether propofol could attenuate the infarct size and improve the neurobehavioral outcome in rats subjected to permanent middle cerebral artery occlusion in vivo.
Results: When present in the incubation medium during oxygen-glucose deprivation and the subsequent 24 h recovery period, propofol (10–100 μm) attenuated CA1 injury in hippocampal slices in vitro. Ca2+-induced brain mitochondrial swelling was prevented by 30–100 μm propofol, and so were the ultrastructural mitochondrial changes in CA1 pyramidal cells exposed to oxygen-glucose deprivation. Twenty-four hours after permanent middle cerebral artery occlusion, propofol (100 mg/kg, intraperitoneal) reduced the infarct size by approximately 30% when administered immediately after and up to 30 min after the occlusion. Finally, propofol administered within 30 min after middle cerebral artery occlusion was unable to affect the global neurobehavioral score but significantly preserved spontaneous activity in ischemic rats.
Conclusions: These results show that propofol, at clinically relevant concentrations, is neuroprotective in models of cerebral ischemia in vitro and in vivo and that it may act by preventing the increase in neuronal mitochondrial swelling.
PROPOFOL (2,6-diisopropylphenol) is an intravenous sedative–hypnotic agent commonly used in anesthesia and intensive care that has been tested as a neuroprotective agent in models of cerebral ischemia. Both positive1–4
results have emerged from in vitro
studies. Similarly, in vivo
studies have yielded conflicting results: Propofol seems to be able to reduce the extent of postischemic damage in models of transient8–12
but not permanent13
focal ischemia. A number of mechanisms have been claimed to explain the neuroprotective effects of propofol, including reduction of the cerebral metabolic rate for oxygen,8
antioxidant activity toward both lipophilic and hydrophilic radicals,1,14,15
activation of γ-aminobutyric acid type A receptors,16,17
inhibition of glutamate receptors,18,19
and reduction of extracellular glutamate concentrations via
inhibition of Na+
channel–dependent glutamate release20
or enhancement of glutamate uptake.1,3
Mitochondria are involved in the energetic supply and are implicated in ischemic dysfunction in all living cells, especially in neurons.21
The oxidative phosphorylation activity of neuronal mitochondria rapidly deteriorates under ischemic conditions, leading to energetic failure and cell death. Moreover, as a consequence of ischemic oxidative stress and mitochondrial Ca2+
overload, the mitochondrial permeability transition pore (MPTP) opens, allowing the free movement of small-molecular-weight solutes but not of proteins.22,23
This results in mitochondrial swelling and eventually in rupture of the outer membrane and release of proapoptotic factors, such as cytochrome C—which can also be released in an MPTP-independent manner24
—and the apoptotic inducible factor, that are normally sequestered and maintained inactivated in the space between the inner and outer mitochondrial membranes.21
Accordingly, drugs capable of preventing increases in mitochondrial membrane permeability, such as cyclosporine, protect cerebral tissue against ischemia-induced damage.25
Propofol has been shown to enhance postischemic functional recovery in the heart by inhibiting the opening of the MPTP,26,27
but no studies have yet been conducted in the brain.
In the current study, we evaluated the neuroprotective effects of propofol, at clinically relevant concentrations, in rat organotypic hippocampal slices exposed to oxygen-glucose deprivation (OGD), an in vitro
model of cerebral ischemia we have been extensively using in our laboratory.28
Then, to elucidate its mechanism of action, we examined whether propofol could act by reducing Ca2+
-induced rat brain mitochondrial swelling, an index of increased mitochondrial membrane permeability, and whether it could prevent the ultrastructural mitochondrial changes evoked by OGD in CA1 pyramidal cells. Finally, we examined the effects of propofol on the extent of the infarct and the neurobehavioral outcome in rats subjected to permanent middle cerebral artery occlusion (MCAO), a severe model of focal ischemia in vivo
Materials and Methods
The experimental protocol was conducted according to the Italian guidelines for animal care (DL 116/92) in application of the European Communities Council Directive (86/609/EEC) and was formally approved by the Animal Care Committee of the Department of Pharmacology of the University of Florence (Florence, Italy).
Propofol (2,6-diisopropylphenol) in an intralipid emulsion (Diprivan) was supplied by Astra-Zeneca (Basiglio, Milano, Italy). The lipid vehicle (Intralipid) was purchased from Fresenius Kabi (Verona, Italy). For in vitro experiments, pure propofol (Sigma-Aldrich, Milano, Italy) was used and dissolved in dimethylsulfoxide (0.1% final concentration). Propidium iodide (PI) was purchased from Molecular Probes (Leiden, The Netherlands), 2,3,5-triphenyl-2H-tetrazolium chloride (tetrazolium red) from Sigma-Aldrich. Tissue culture reagents were obtained from GIBCO-BRL (San Giuliano Milanese, Milano, Italy) and ICN Pharmaceuticals (Opera, Milano, Italy).
OGD and Assessment of CA1 Pyramidal Cell Injury in Organotypic Rat Hippocampal Slices
Organotypic hippocampal slice cultures were prepared as previously reported.29
The hippocampi were removed from the brains of 8-day-old Wistar rats (Harlan-Nossan, Udine, Italy), and transverse slices (420 μm) were prepared using a McIlwain tissue chopper in a sterile environment. Isolated slices were first placed into ice-cold Hanks' balanced salt solution supplemented with 5 mg/ml glucose and 1.5% Fungizone (GIBCO BRL) and then transferred to humidified semiporous membranes (30 mm Millicell-CM 0.4-μm tissue culture plate inserts; Millipore, Rome, Italy; four per membrane). These were placed in six-well tissue culture plates containing 1.2 ml medium containing 50% Eagle's minimal essential medium, 25% heat-inactivated horse serum, 24% Hanks' balanced solution, 5 mg/ml glucose, 1 mm glutamine, and 1.5% Fungizone. Slices were maintained at 37°C and 100% humidity in a 95% air–5% CO2
atmosphere, and the medium was changed every 4 days. Experiments were conducted after 14 days in vitro
Oxygen-glucose deprivation was induced as previously described.29
Organotypic hippocampal slices were preincubated for 30 min in serum-free medium and then subjected to OGD by exposing them to a serum-free medium devoid of glucose and previously saturated with 95% N2
. After 30 min of incubation at 37°C in an airtight anoxic chamber (PROOX model 110; BioSpherix, Redfield, NY), the cultures were transferred to oxygenated serum-free medium containing 5 mg/ml glucose and 5 μg/ml PI and returned to the incubator under normoxic conditions until neuronal injury was evaluated 24 h later. Under these experimental conditions, 30 min of OGD induces a CA1 pyramidal cell damage that is approximately 70% of the maximal damage achieved by exposing the slices for 24 h to 10 mm glutamate (see Pellegrini-Giampietro et al.29
). Propofol (1, 10, 30, and 100 μm) was added to the incubation medium during the 30-min OGD injury and the subsequent 24-h recovery period. Cell injury was assessed using PI, a polar dye that enters the cells only if the membrane is damaged and becomes fluorescent after binding to DNA. PI fluorescence was viewed using an Intracellular Imaging Inc. (Cincinnati, OH) imaging system, consisting of a xenon-arc lamp, a Nikon TMS-F inverted microscope equipped with a fluorescence optics module for epi-illumination, a low-power objective (4×), and a rhodamine filter set. To quantify cell death, the CA1 hippocampal subfield was identified and encompassed by a frame using the drawing function in the image software, and the intensity of PI fluorescence (i.e.
, the mean of the fluorescence intensity values of each pixel in the area defined by the frame) was collected (for details, see Pellegrini-Giampietro et al.29
). Background PI fluorescence was determined in control cultures not exposed to OGD and was subtracted from all experimental values. There was a linear correlation between PI fluorescence and the number of injured CA1 pyramidal cells as detected by morphological criteria (see Pellegrini-Giampietro et al.29
Isolation of Brain Mitochondria and Measurement of Mitochondrial Swelling
Swelling of isolated mitochondria is a recognized index of increased mitochondrial membrane permeability.30–32
Brain mitochondria were isolated by differential centrifugation, according to Lindenmayer et al.33
Briefly, brains of adult Sprague-Dawley rats (Harlan-Nossan, Udine, Italy) (weight, 280–310 g) were quickly removed and homogenized by Ultra-Turrax in 5 ml of an ice-cold medium containing 300 mm sucrose, 5 mg/ml bovine serum albumin, 2 mm EDTA, and 10 mm TRIS-HCl (pH 7.4). The whole homogenate was centrifuged for 5 min at 3,000g
to pellet nuclei and unbroken cells. Subsequently, the supernatant was spun at 12,000g
for 5 min to sediment mitochondria. The pellet was washed and then resuspended in 1 ml ice-cold bovine serum albumin–free and EDTA-free sucrose buffer (300 mm sucrose, 10 mm TRIS-HCl, pH 7.4) to give a mitochondrial protein content of 0.25 mg/ml. A fixed volume (25 μl) of mitochondrial suspension was diluted in 1 ml bovine serum albumin–free and EDTA-free sucrose buffer at 25°C. Ca2+
-induced swelling of mitochondria was monitored as the decrease in light scattering at 540 nm for 5 min with a Perkin-Elmer Lambda 5 spectrophotometer, according to Halestrap et al.30
Propofol (30 or 100 μm final concentration) dissolved in dimethyl sulfoxide was added to the mitochondrial suspension 1 min before CaCl2
(100–1,000 μm) exposure. Controls were preincubated with an equal concentration of dimethylsulfoxide (0.1%, final concentration).
Transmission Electron Microscopy
The effects of propofol on the mitochondrial ultrastructural changes of CA1 pyramidal cells evoked by OGD were analyzed in organotypic hippocampal slices by transmission electron microscopy. Slices were gently removed from the culture dishes with a brush, fixed in Karnowsky solution for 2 h at room temperature, and then postfixed in 1% osmium tetroxide (in 0.1 m phosphate buffer, pH 7.4) for 1 h at 4°C. Hippocampal slices were then dehydrated in graded acetone, passed through propylene oxide, and embedded in Epon 812. Ultrathin sections were stained with uralyl acetate and alkaline bismuth and viewed under a Jeol 1010 (Tokyo, Japan) electron microscope at 80 kV.
Permanent MCAO in Rats
Adult male Sprague-Dawley rats weighing 250–280 g were used. All animals were fasted overnight before the experiment but had free access to water. Animals were initially anesthetized in a container with 5% isoflurane until the righting reflex became unapparent; then the anesthetic state was maintained with isoflurane (1–2%) delivered in an air–oxygen mixture (60 and 40%, respectively) through a facemask. Efficacy of ventilation and oxygenation was assessed by measuring carbon dioxide and oxygen tension in tail artery blood samples. Blood pressure was monitored noninvasively. Body temperature was monitored with a rectal probe and maintained at 37° ± 0.5°C with a thermostatically controlled heating pad. Permanent MCAO was induced using a relatively noninvasive technique with an intraluminal filament according to Zea Longa et al.34
Silicon-coated nylon filaments (external diameter, 0.28 mm) were prepared. The external and internal right carotid arteries were dissected under an operating microscope, and a silk suture was tied loosely around the external carotid stump. The silicone-coated nylon filament was then inserted through the external into the internal carotid artery up to the circle of Willis to occlude the right middle cerebral artery. The silk suture was finally tightened around the intraluminal filament to prevent bleeding and dislodgment. Recovery of the righting reflex occurred approximately 5 min after isoflurane administration was terminated, and the animals were returned to their cages. Vehicle-treated animals received an equivalent concentration of 10% Intralipid immediately after MCAO; treated animals received 100 mg/kg Diprivan intraperitoneally immediately after and at 15, 30, and 90 min after MCAO.
Twenty-four hours after ischemia, rats were anesthetized with chloral hydrate (400 mg/kg, intraperitoneal) and then decapitated. Brains were quickly removed and inspected to confirm the position of the intraluminal filament and the absence of subarachnoid hemorrhage. Brains were then coronally sectioned with a tissue chopper at 2-mm intervals, incubated for 30 min in a 2% solution of 2,3,5-triphenyl-2H-tetrazolium chloride at 37°C for vital staining, and fixed by immersion in 4% paraformaldehyde in phosphate buffer (pH 7.4). 2,3,5-Triphenyl-2H-tetrazolium chloride–stained sections were computer scanned, and the infarct areas were outlined and measured using an image analysis system (Image Pro Plus 3.0; Silver Spring, MD). Infarct volumes were calculated as previously described in detail35
and, to correct for swelling of the ischemic hemisphere, the following formula was applied, in which brain swelling corresponds to the difference in brain volume between the two hemispheres: Corrected Infarct Volume = Left Hemisphere Volume − (Right Hemisphere Volume − Measured Infarct Volume).36
Neurobehavioral Evaluation after MCAO in Rats
After MCAO, the occurrence of a turning behavior ipsilateral to the ischemic side upon tail stimulation was searched as an index of ischemia in the territory of the middle cerebral artery. To assess the neuroprotective effects of propofol, a neurobehavioral examination according to Garcia et al.37
was performed immediately before and 24 h after MCAO. Each rat was assigned a score in six different tests (maximal global score = 18, minimal global score = 3). This testing assesses the following: spontaneous activity—no movement (0 points) to normal behavior (3 points); motor symmetry in all limbs—no movement at the left side (0 points) to normal behavior (3 points); symmetry in the outstretching of forelimbs—no movement (0 points) to normal motor symmetry (3 points); climbing—falls trying to climb (1 point) to normal climbing (3 points); body proprioception—no response at the left side (1 point) to symmetrical response (3 points); and response to vibrissae touch—no response on the left side (1 point) to symmetrical response (3 points). Neurobehavioral testing was performed by a single observer blinded to group assignment. To avoid the influence of daily fluctuations in neurologic performance, the evaluation was conducted at the same time of day.
Statistical analysis was performed using analysis of variance followed by the Tukey w test for multiple comparisons. For neurobehavioral scores, the nonparametric Kruskal-Wallis test was used, followed by the Dunn post hoc test. Differences were considered significant for P < 0.05.
Neuroprotective Effects of Propofol against OGD in Rat Organotypic Hippocampal Slices
Hippocampal slices cultured for 14 days in vitro
retained an organotypic organization in which the pyramidal and granule cell layers could be clearly defined when observed under phase-contrast microscopy or after toluidine blue staining.29
Control slices incubated with PI displayed low fluorescence levels, but when cultures were subjected to OGD for 30 min, PI staining increased dramatically in the hippocampal CA1 area 24 h later (fig. 1A
). Selective vulnerability of CA1 pyramidal cell death is a hallmark of severe global ischemia in patients successfully resuscitated from cardiorespiratory arrest38
or in experimental animal models.39,40
Quantitative analysis revealed that OGD induced an increase in PI fluorescence in the CA1 region that was approximately 65% of the maximal fluorescence intensity obtained by exposing the slices to 10 mm glutamate (see Pellegrini-Giampietro et al.29
). The addition of 10, 30, and 100 μm propofol (but not of the vehicle dimethylsulfoxide) to the incubation medium during OGD and the subsequent 24-h recovery period significantly reduced CA1 injury by 35 ± 4, 40 ± 5, and 43 ± 5%, respectively (figs. 1B and C
). Exposure of slices to propofol alone for 24 h did not induce any increase in PI fluorescence (not shown).
Effects of Propofol on Mitochondrial Swelling
To investigate the possible mechanism of action of propofol, we then examined its effects on brain mitochondria.
Propofol Reduces Ca2+-induced Brain Mitochondrial Swelling.
The exposure of rat brain isolated mitochondria to CaCl2
(100–1,000 μm) induced a dose-dependent increase in mitochondrial swelling, as detected by a decrease in light transmission (fig. 2A
). The addition of 100 μm propofol prevented the Ca2+
-induced decrease in light transmission (figs. 2B and C
); a similar effect was observed with 30 μm propofol (not shown). The effect was significant at 200–300 μm CaCl2
and, notably, persisted for at least 5 min after the stimulus.
Propofol Reduces OGD-induced Mitochondrial Swelling in CA1 Pyramidal Cells.
To determine whether these findings on isolated brain mitochondria are relevant to ischemia, we used transmission electron microscopy to examine the effects of propofol on the OGD-induced mitochondrial damage of CA1 pyramidal cells in hippocampal slices. Observation of control hippocampal slices under the electron microscope (fig. 3
) revealed the appearance of healthy, triangular-shaped CA1 pyramidal cells, displaying a large nucleus, dispersed chromatin, a well-defined nucleolus, and a cytoplasm rich in organelles and lipofuscin (not shown; see also Moroni et al.41
). Mitochondria were elongated or round and had numerous transversae cristae with a regular pattern and an electron-dense intramitochondrial matrix. After OGD, CA1 pyramidal cell mitochondria showed substantial ultrastructural alterations, such as swelling (i.e.
, enlarged size with an electron-lucent matrix), disruption of cristae, and fragmentation of internal membranes. Treatment with 30 or 100 μm propofol exerted a protective effect on CA1 pyramidal cell mitochondria: The frequency and the extent of the ultrastructural abnormalities were markedly reduced. In particular, the treatment substantially decreased the ischemia-induced mitochondrial swelling.
Propofol Reduces the Infarct Size after Permanent MCAO in Rats
Rats not displaying a clear-cut turning behavior after MCAO and rats with subarachnoid hemorrhage at postmortem examination were excluded from the study. Physiologic parameters did not differ significantly among rat groups (table 1
). Permanent MCAO in vehicle-treated rats led to the formation of a large infarct in the ipsilateral hemisphere that 24 h later affected a significant portion of the frontal and parietal cortex, the caudate-putamen, and the diencephalon (fig. 4A
). Administration of 100 mg/kg intraperitoneal propofol (but not of the Intralipid vehicle) immediately after the occlusion reduced the extent of the infarct (fig. 4B
); the effect was particularly evident and reached statistical significance in the most anterior portions of the brain (figs. 4B and C
). The volume of the infarct produced by MCAO was 426 ± 24 mm3
(mean ± SEM); propofol significantly reduced the extension by approximately 30 ± 4%. A quantitatively similar degree of protection was obtained when the drug was administered 15 and 30 but not 90 min after MCAO (fig. 4D
). Finally, a comparable degree of neuroprotection was observed when the infarct volume was corrected for swelling of the ischemic hemisphere (data not shown).
Propofol Improves Spontaneous Activity after Permanent MCAO in Rats
MCAO induced a significant reduction in the global neurobehavioral score, when observed 24 h after the occlusion (table 2
). The global neurobehavioral global score was not modified by treatment with propofol. However, when individual tasks were compared, propofol administered within 30 min after MCAO significantly preserved spontaneous activity in ischemic rats.
Our results show that propofol at clinically relevant concentrations7,42–44
is neuroprotective in models of cerebral ischemia in vitro
and in vivo
. In vitro
, propofol attenuated CA1 pyramidal cell death in rat organotypic hippocampal slices exposed to OGD in a concentration-dependent fashion, prevented the Ca2+
-induced increase in membrane permeability in isolated rat brain mitochondria, and reduced the ultrastructural mitochondrial changes evoked by OGD in CA1 pyramidal cells. In vivo
, rats subjected to permanent MCAO and treated with propofol displayed, 24 h later, smaller infarcts and improved spontaneous activity as compared with vehicle-treated rats, even when propofol administration was delayed up to 30 min after vascular occlusion.
Propofol (10–100 μm) was able to attenuate CA1 pyramidal cell injury in organotypic hippocampal slices exposed to OGD. Previous reports had shown that propofol reduces neurotransmission damage induced by anoxia45
but not by OGD6,46
in acute hippocampal slices. These controversial results may be ascribed to the fact that organotypic cultures are quite different from acute hippocampal slices, being prepared from neonatal rats and cultured for 14 days until they mature and retain an organization and functional characteristics very similar to what occurs in vivo
However, in a recent report, Feiner et al.7
were unable to demonstrate neuroprotection with 10–100 μm propofol in a similar organotypic hippocampal slice model. It should be noted that in their study, OGD injury was more severe, because the duration of exposure was more prolonged (1 h vs.
30 min) and neuronal death was not selective to the CA1 region, as occurs in vivo
. Our model, therefore, may be more amenable to pharmacologic intervention with drugs as propofol that are neuroprotective in models of transient forebrain ischemia in vivo
There are several mechanisms that may explain the neuroprotective effects of propofol, including its capability of modulating glutamate neurotransmission and its antioxidant properties. However, the results of studies on these mechanisms have not been consistent. Propofol restores glutamate uptake in ascorbate-depleted astrocytes exposed to peroxyl radicals,1
reduces potassium-evoked glutamate release in rat cerebrocortical slices,52
and significantly counteracts OGD-induced increase of extracellular glutamate concentrations in neuronal cultures, presumably by restoring glutamate uptake.3
However, in freshly prepared rat hippocampal slices, propofol impairs the recovery of CA1 population spikes from N
Moreover, propofol directly inhibits N
-methyl-d-aspartate receptors only at high concentrations (> 160 μm),19
and its neuroprotective effect in rats subjected to global ischemia does not seem to be due to a reduction in extracellular glutamate concentrations.50
Propofol has repeatedly been demonstrated to have antioxidant properties,14,42
although in an in vivo
study, neuroprotection with propofol could not be ascribed to a modification of low-molecular-weight antioxidants.12
Postischemic energy failure and activation of apoptosis in neurons are regulated at multiple levels, and an increase in mitochondrial membrane permeability is now accepted to play a major role.21
Propofol has been shown to ameliorate reperfusion injury in the rat heart by inhibiting the opening of the MPTP,26,27
but no studies have yet been conducted in the brain. We therefore examined the effects of propofol on brain mitochondria under two conditions that simulate cerebral ischemia: an overload of CaCl253,54
in isolated brain mitochondria and OGD injury in hippocampal slices. Propofol prevented mitochondrial swelling in both circumstances at 30 and 100 μm, concentrations that have been reported to directly inhibit the MPTP in the heart27
and are generally retained to correspond to the concentrations that, because of its high lipid–water coefficient partition, can be reached in the brain during anesthesia7,11,43,55
These findings suggest that an effect of propofol on mitochondria might also be important in the ischemic setting in vivo
, by directly inhibiting the MPTP or, indirectly, by modulating the production/concentration of other cytotoxic mediators, such as free radicals, glutamate, or calcium that can alter the integrity of mitochondria or trigger the opening of the MPTP.21,27
Propofol has been repeatedly demonstrated to be neuroprotective in transient models of global50,56
and focal ischemia induced by both MCAO8,10,57
or endothelin-1 intrastriatal injection in awake rats.11,12
Despite that acute ischemic stroke in humans is frequently thromboembolic in nature and rarely undergoes spontaneous reperfusion,58
the effects of propofol in permanent MCAO have not been yet investigated. A report by Tsai et al.13
failed to demonstrate a protective action of propofol after permanent MCAO, but in this study, it was combined with bilateral carotid occlusion. We observed that the overall mean infarction size was significantly reduced in rats receiving propofol within 30 min after MCAO and that the protection was particularly evident in the most anterior coronal sections (slices 1–3), in areas that include the frontoparietal cortex. Propofol also preserved spontaneous activity after MCAO but did not affect other neurologic tasks or the mean global neurobehavioral score. Permanent MCAO in rats produces an ischemic core in the caudate-putamen and a penumbral area in the frontoparietal cortex, where a network of surface collateral connections exists and allows a certain degree of reperfusion.37
Spontaneous activity, as evaluated according to Garcia et al.
is an index of rat normal exploring behavior rather than of motor function and thus requires the integrity of the frontal cortex.
In our permanent MCAO model, propofol induced neuroprotection to a somewhat lesser degree when compared with that reported in models of transient focal ischemia.11,12,57
This could be attributed to the model itself, which in our case is more severe and does not include reperfusion of the right middle cerebral artery, or to the fact that we administered propofol in a single administration and not by continuous infusion. The total amount of propofol we administered, however, is in accord with the study of Arcadi et al.56
showing that propofol at a single dose of 50 and 100 but not 25 mg/kg intraperitoneally attenuates CA1 injury after global ischemia in gerbils. In our study, we limited the period of evaluation of neuroprotection, in terms of both anatomical lesion and neurologic outcome, to the first 24 h after MCAO. Therefore, we cannot rule out a transient protective effect of propofol in our model, as reported for other anesthetics.59
However, in a model of incomplete cerebral ischemia and reperfusion, propofol offered long-term neuroprotection.60
Moreover, early evaluation of the neuroprotective effects of propofol seems to be predictive of prolonged functional improvement in rats exposed to mild focal ischemia.12
There are a number of issues in this study that still must be clarified. (1) Although we have demonstrated that propofol directly reduces Ca2+
-induced swelling in isolated mitochondria, it is possible that propofol may act upstream of mitochondria in our in vitro
and in vivo
models of ischemia, perhaps by interacting with other cytotoxic events (i.e.
, glutamate receptor activation, impairment of glutamate uptake, free radical production) that may or may not involve changes in intracellular free Ca2+
concentrations and mitochondrial membrane permeability. (2) Because we used a recovery interval of 24 h in hippocampal slices exposed to OGD and in rats after MCAO, we cannot exclude a transient neuroprotective effect for propofol. (3) The concentrations of propofol that we used have been reported to be in the anesthetic range by some authors43,44,55
but are considered to be high by others.
Despite these limitations, our study shows that propofol is neuroprotective in organotypic hippocampal slices exposed to OGD in vitro, possibly by preventing the ischemic increase in brain mitochondrial membrane permeability. In a severe model of focal cerebral ischemia in vivo, propofol reduces the size of the infarct and preserved spontaneous activity, even when drug administration is delayed up to 30 min after the occlusion of the middle cerebral artery.
The authors thank Prof. Lucia Formigli, B.Sc. (Dipartimento di Anatomia, Istologia e Medicina Legale, Università di Firenze, Florence, Italy), for help with the transmission electron microscopy.
1. Sitar SM, Hanifi-Moghaddam P, Gelb A, Cechetto DF, Siushansian R, Wilson JX: Propofol prevents peroxide-induced inhibition of glutamate transport in cultured astrocytes. Anesthesiology 1999; 90:1446–53
2. Peters CE, Korcok J, Gelb AW, Wilson JX: Anesthetic concentrations of propofol protect against oxidative stress in primary astrocyte cultures: Comparison with hypothermia. Anesthesiology 2001; 94:313–21
3. Velly LJ, Guillet BA, Masmejean FM, Nieoullon AL, Bruder NJ, Gouin FM, Pisano PM: Neuroprotective effects of propofol in a model of ischemic cortical cell cultures: Role of glutamate and its transporters. Anesthesiology 2003; 99:368–75
4. Daskalopoulos R, Korcok J, Farhangkhgoee P, Karmazyn M, Gelb AW, Wilson JX: Propofol protection of sodium-hydrogen exchange activity sustains glutamate uptake during oxidative stress. Anesth Analg 2001; 93:1199–204
5. Zhu H, Cottrell JE, Kass IS: The effect of thiopental and propofol on NMDA- and AMPA-mediated glutamate excitotoxicity. Anesthesiology 1997; 87:944–51
6. Qi S, Zhan RZ, Wu C, Fujihara H, Taga K, Shimoji K: The effects of thiopental and propofol on cell swelling induced by oxygen/glucose deprivation in the CA1 pyramidal cell layer of rat hippocampal slices. Anesth Analg 2002; 94:655–60
7. Feiner JR, Bickler PE, Estrada S, Donohoe PH, Fahlman CS, Schuyler JA: Mild hypothermia, but not propofol, is neuroprotective in organotypic hippocampal cultures. Anesth Analg 2005; 100:215–25
8. Kochs E, Hoffman WE, Werner C, Thomas C, Albrecht RF, Schulte am EJ: The effects of propofol on brain electrical activity, neurologic outcome, and neuronal damage following incomplete ischemia in rats. Anesthesiology 1992; 76:245–52
9. Ridenour TR, Warner DS, Todd MM, Gionet TX: Comparative effects of propofol and halothane on outcome from temporary middle cerebral artery occlusion in the rat. Anesthesiology 1992; 76:807–12
10. Pittman JE, Sheng H, Pearlstein R, Brinkhous A, Dexter F, Warner DS: Comparison of the effects of propofol and pentobarbital on neurologic outcome and cerebral infarct size after temporary focal ischemia in the rat. Anesthesiology 1997; 87:1139–44
11. Gelb AW, Bayona NA, Wilson JX, Cechetto DF: Propofol anesthesia compared to awake reduces infarct size in rats. Anesthesiology 2002; 96:1183–90
12. Bayona NA, Gelb AW, Jiang Z, Wilson JX, Urquhart BL, Cechetto DF: Propofol neuroprotection in cerebral ischemia and its effects on low-molecular-weight antioxidants and skilled motor tasks. Anesthesiology 2004; 100:1151–9
13. Tsai YC, Huang SJ, Lai YY, Chang CL, Cheng JT: Propofol does not reduce infarct volume in rats undergoing permanent middle cerebral artery occlusion. Acta Anaesthesiol Sin 1994; 32:99–104
14. Murphy PG, Myers DS, Davies MJ, Webster NR, Jones JG: The antioxidant potential of propofol (2,6-diisopropylphenol). Br J Anaesth 1992; 68:613–8
15. Tsuchiya M, Asada A, Maeda K, Ueda Y, Sato EF, Shindo M, Inoue M: Propofol versus midazolam regarding their antioxidant activities. Am J Respir Crit Care Med 2001; 163:26–31
16. Ito H, Watanabe Y, Isshiki A, Uchino H: Neuroprotective properties of propofol and midazolam, but not pentobarbital, on neuronal damage induced by forebrain ischemia, based on the GABAA receptors. Acta Anaesthesiol Scand 1999; 43:153–62
17. Buggy DJ, Nicol B, Rowbotham DJ, Lambert DG: Effects of intravenous anesthetic agents on glutamate release: A role for GABAA receptor–mediated inhibition. Anesthesiology 2000; 92:1067–73
18. Yamakura T, Sakimura K, Shimoji K, Mishina M: Effects of propofol on various AMPA-, kainate- and NMDA-selective glutamate receptor channels expressed in Xenopus oocytes. Neurosci Lett 1995; 188:187–90
19. Orser BA, Bertlik M, Wang LY, MacDonald JF: Inhibition by propofol (2,6 di-isopropylphenol) of the N-methyl-D-aspartate subtype of glutamate receptor in cultured hippocampal neurones. Br J Pharmacol 1995; 116:1761–8
20. Lingamaneni R, Birch ML, Hemmings Jr HC: Widespread inhibition of sodium channel–dependent glutamate release from isolated nerve terminals by isoflurane and propofol. Anesthesiology 2001; 95:1460–6
21. Mattson MP, Kroemer G: Mitochondria in cell death: Novel targets for neuroprotection and cardioprotection. Trends Mol Med 2003; 9:196–205
22. Wang X: The expanding role of mitochondria in apoptosis. Genes Dev 2001; 15:2922–33
23. Penninger JM, Kroemer G: Mitochondria, AIF and caspases: Rivaling for cell death execution. Nat Cell Biol 2003; 5:97–9
24. Petrosillo G, Ruggiero FM, Pistolese M, Paradies G: Ca2+-induced reactive oxygen species production promotes cytochrome c release from rat liver mitochondria via mitochondrial permeability transition (MPT)-dependent and MPT-independent mechanisms: Role of cardiolipin. J Biol Chem 2004; 279:53103–8
25. Matsumoto S, Friberg H, Ferrand-Drake M, Wieloch T: Blockade of the mitochondrial permeability transition pore diminishes infarct size in the rat after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab 1999; 19:736–41
26. Halestrap AP, Clarke SJ, Javadov SA: Mitochondrial permeability transition pore opening during myocardial reperfusion: A target for cardioprotection. Cardiovasc Res 2004; 61:372–85
27. Javadov SA, Lim KH, Kerr PM, Suleiman MS, Angelini GD, Halestrap AP: Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc Res 2000; 45:360–9
28. Pellegrini-Giampietro DE: The distinct role of mGlu1 receptors in post-ischemic neuronal death. Trends Pharmacol Sci 2003; 24:461–70
29. Pellegrini-Giampietro DE, Cozzi A, Peruginelli F, Leonardi P, Meli E, Pellicciari R, Moroni F: 1-Amino-1,5-dicarboxylic acid and (S)-(+)-2-(3|o:-carboxybicyclo[1.1.1]pentyl)-glycine, two mGlu1 receptor-preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischemia. Eur J Neurosci 1999; 11:3637–47
30. Halestrap AP: Calcium-dependent opening of a non-specific pore in the mitochondrial inner membrane is inhibited at pH values below 7: Implications for the protective effect of low pH against chemical and hypoxic cell damage. Biochem J 1991; 278 (pt 3):715–9
31. Sztark F, Ichas F, Ouhabi R, Dabadie P, Mazat JP: Effects of the anaesthetic propofol on the calcium-induced permeability transition of rat heart mitochondria: Direct pore inhibition and shift of the gating potential. FEBS Lett 1995; 368:101–4
32. Di Lisa F, Menabo R, Canton M, Barile M, Bernardi P: Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem 2001; 276:2571–5
33. Lindenmayer GE, Sordahl LA, Schwartz A: Reevaluation of oxidative phosphorylation in cardiac mitochondria from normal animals and animals in heart failure. Circ Res 1968; 23:439–50
34. Longa EZ, Weinstein PR, Carlson S, Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20:84–91
35. Cozzi A, Carpenedo R, Moroni F: Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (RO 61-8048) in models of focal or global ischemia. J Cereb Blood Flow Metab 1999; 19:771–7
36. Belayev L, Zhao W, Pattany PM, Weaver RG, Huh PW, Lin B, Busto R, Ginsberg MD: Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia. Stroke 1998; 29:2587–99
37. Garcia JH, Wagner S, Liu KF, Hu XJ: Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats: Statistical validation. Stroke 1995; 26:627–34
38. Petito C, Feldmann E, Pulsinelli W, Plum F: Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology 1987; 37:1281–6
39. Kirino T: Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 1982; 239:57–69
40. Pulsinelli WA, Brierley JB, Plum F: Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 1982; 11:491–8
41. Moroni F, Meli E, Peruginelli F, Chiarugi A, Cozzi A, Picca R, Romagnoli P, Pellicciari DE, Pellegrini-Giampietro R: Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia. Cell Death Differ 2001; 8:921–32
42. Wilson JX, Gelb AW: Free radicals, antioxidants, and neurologic injury: Possible relationship to cerebral protection by anesthetics. J Neurosurg Anesthesiol 2002; 14:66–79
43. Tsuchiya M, Asada A, Arita K, Utsumi T, Yoshida T, Sato EF, Utsumi K, Inoue M: Induction and mechanism of apoptotic cell death by propofol in HL-60 cells. Acta Anaesthesiol Scand 2002; 46:1068–74
44. Riu PL, Riu G, Testa C, Mulas M, Caria MA, Mameli S, Mameli O: Disposition of propofol between red blood cells, plasma, brain and cerebrospinal fluid in rabbits. Eur J Anaesthesiol 2000; 17:18–22
45. Amorim P, Chambers G, Cottrell J, Kass IS: Propofol reduces neuronal transmission damage and attenuates the changes in calcium, potassium, and sodium during hyperthermic anoxia in the rat hippocampal slice. Anesthesiology 1995; 83:1254–65
46. Zhan RZ, Qi S, Wu C, Fujihara H, Taga K, Shimoji K: Intravenous anesthetics differentially reduce neurotransmission damage caused by oxygen-glucose deprivation in rat hippocampal slices in correlation with N-methyl-D-aspartate receptor inhibition. Crit Care Med 2001; 29:808–13
47. Stoppini L, Buchs PA, Muller D: A simple method for organotypic cultures of nervous tissue. J Neurosci Meth 1991; 37:173–82
48. Muller D, Buchs PA, Stoppini L: Time course of synaptic development in hippocampal organotypic cultures. Brain Res Dev Brain Res 1993; 71:93–100
49. Abdel-Hamid KM, Tymianski M: Mechanisms and effects of intracellular calcium buffering on neuronal survival in organotypic hippocampal cultures exposed to anoxia/aglycemia or to excitotoxins. J Neurosci 1997; 17:3538–53
50. Yano T, Nakayama R, Ushijima K: Intracerebroventricular propofol is neuroprotective against transient global ischemia in rats: Extracellular glutamate level is not a major determinant. Brain Res 2000; 883:69–76
51. Ergun R, Akdemir G, Sen S, Tasci A, Ergungor F: Neuroprotective effects of propofol following global cerebral ischemia in rats. Neurosurg Rev 2002; 25:95–8
52. Buggy DJ, Asher MJ, Lambert DG: Nimodipine premedication and induction dose of propofol. Anesth Analg 2000; 90:445–9
53. Budd SL: Mechanisms of neuronal damage in brain hypoxia/ischemia: Focus on the role of mitochondrial calcium accumulation. Pharmacol Ther 1998; 80:203–29
54. Kristian T: Metabolic stages, mitochondria and calcium in hypoxic/ischemic brain damage. Cell Calcium 2004; 36:221–33
55. Shyr MH, Tsai TH, Tan PP, Chen CF, Chan SH: Concentration and regional distribution of propofol in brain and spinal cord during propofol anesthesia in the rat. Neurosci Lett 1995; 184:212–5
56. Arcadi FA, Rapisarda A, De Luca R, Trimarchi GR, Costa G: Effect of 2,6-diisopropylphenol on the delayed hippocampal cell loss following transient forebrain ischemia in the gerbil. Life Sci 1996; 58:961–70
57. Wang J, Yang X, Camporesi CV, Yang Z, Bosco G, Chen C, Camporesi EM: Propofol reduces infarct size and striatal dopamine accumulation following transient middle cerebral artery occlusion: A microdialysis study. Eur J Pharmacol 2002; 452:303–8
58. Schellinger PD, Kaste M, Hacke W: An update on thrombolytic therapy for acute stroke. Curr Opin Neurol 2004; 17:69–77
59. Kawaguchi M, Kimbro JR, Drummond JC, Cole DJ, Kelly PJ, Patel PM: Isoflurane delays but does not prevent cerebral infarction in rats subjected to focal ischemia. Anesthesiology 2000; 92:1335–42
60. Engelhard K, Werner C, Eberspacher E, Pape M, Blobner M, Hutzler P, Kochs E: Sevoflurane and propofol influence the expression of apoptosis-regulating proteins after cerebral ischaemia and reperfusion in rats. Eur J Anaesthesiol 2004; 21:530–7
This article has been cited 21 time(s).
Acta PaediatricaClinical evaluation of propofol as sedative for endotracheal intubation in neonatesActa Paediatrica
Journal of Cardiothoracic and Vascular AnesthesiaHigh-Dose Propofol Reduces S-100 beta Protein and Neuron-Specific Enolase Levels in Patients Undergoing Cardiac SurgeryJournal of Cardiothoracic and Vascular Anesthesia
Neurological SciencesPropofol exerts hippocampal neuron protective effects via up-regulation of metallothionein-3Neurological Sciences
European Journal of PharmacologyPropofol: A review of its non-anaesthetic effectsEuropean Journal of Pharmacology
Critical CarePropofol: neuroprotection in an in vitro model of traumatic brain injuryCritical Care
Chinese Medical Journal
Neuroanesthesia and neuroprotection: where are we now?
Chinese Medical Journal, 119():
CNS Drug Reviews
Neuroprotective effects of propofol in acute cerebral injury
CNS Drug Reviews, 13(3):
CNS Neuroscience & TherapeuticsThe experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective propertiesCNS Neuroscience & Therapeutics
Neural Regeneration ResearchEffect of HX0507, a water-soluble propofol pro-drug, on subarachnoid hemorrhage-induced cerebral vasospasm in rabbitsNeural Regeneration Research
Journal of Clinical NeuroscienceCerebral energy failure after subarachnoid hemorrhage: The role of relative hyperglycolysisJournal of Clinical Neuroscience
Injury-International Journal of the Care of the InjuredTraumatic brain injury: neuroprotective anaesthetic techniques, an updateInjury-International Journal of the Care of the Injured
Acta Anaesthesiologica ScandinavicaHypotension in anaesthetized patients during aneurysm clipping: not as bad as expected?Acta Anaesthesiologica Scandinavica
Rejuvenation ResearchScientific justification of cryonics practiceRejuvenation Research
NeuroscienceEffects of Desflurane and Propofol on Electrophysiological Parameters During and Recovery After Hypoxia in Rat Hippocampal Slice Ca1 Pyramidal CellsNeuroscience
Journal of Cerebral Blood Flow and MetabolismPropofol exerts greater neuroprotection with disodium edetate than without itJournal of Cerebral Blood Flow and Metabolism
Acta Anaesthesiologica ScandinavicaEffects of xenon on ischemic spinal cord injury in rabbits: a comparison with propofolActa Anaesthesiologica Scandinavica
Journal of Neurosurgical AnesthesiologyGlutamate-induced c-Jun Expression in Neuronal PC12 Cells: The Effects of Ketamine and PropofolJournal of Neurosurgical Anesthesiology
Journal of Neurosurgical AnesthesiologyNeuroanesthesiology Review-2006Journal of Neurosurgical Anesthesiology
Journal of Neurosurgical AnesthesiologyNeuroanesthesiology UpdateJournal of Neurosurgical Anesthesiology
© 2006 American Society of Anesthesiologists, Inc.
Publication of an advertisement in Anesthesiology Online does not constitute endorsement by the American Society of Anesthesiologists, Inc. or Lippincott Williams & Wilkins, Inc. of the product or service being advertised.